Axon Enterprise (NASDAQ:AXON) Stock Gets Price Target Reduction from Piper Sandler

Posted by Brian Himes on Oct 20th, 2026

Axon Enterprise (NASDAQ:AXON – Get Free Report) had its target price reduced by stock analysts at Piper Sandler from $732.00 to $561.00 in a research report issued on Tuesday, Benzinga reports. The brokerage presently has an “overweight” rating on the biotechnology company’s stock. Piper Sandler’s price objective would suggest a potential upside of 44.43% from the company’s current price.

A number of other analysts also recently weighed in on AXON. UBS Group increased their price objective on Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a report on Thursday, August 6th. Zacks Research raised Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research report on Monday, October 5th. Citigroup reaffirmed a “market outperform” rating on shares of Axon Enterprise in a report on Thursday, September 17th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $715.00 price target on shares of Axon Enterprise in a research note on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $707.07.

View Our Latest Analysis on AXON

Axon Enterprise Stock Up 1.4%

Shares of NASDAQ AXON opened at $388.41 on Tuesday. The company has a 50 day simple moving average of $497.33 and a 200 day simple moving average of $474.55. The firm has a market cap of $31.55 billion, a PE ratio of 160.39, a price-to-earnings-growth ratio of 7.34 and a beta of 1.44. Axon Enterprise has a 1 year low of $339.01 and a 1 year high of $764.02. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The business had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. During the same period last year, the company earned $2.12 EPS. The firm’s revenue was up 35.3% compared to the same quarter last year. On average, research analysts forecast that Axon Enterprise will post 2.12 EPS for the current year.

Insider Activity

In related news, President Joshua Isner sold 16,775 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $574.43, for a total value of $9,636,063.25. Following the transaction, the president owned 296,974 shares in the company, valued at $170,590,774.82. The trade was a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the company’s stock in a transaction on Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the sale, the insider directly owned 56,264 shares in the company, valued at $27,032,038.80. This trade represents a 1.78% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 47,397 shares of company stock worth $26,722,984 over the last ninety days. Corporate insiders own 4.20% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in AXON. State Street Corp boosted its stake in shares of Axon Enterprise by 5,700.2% in the 2nd quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock worth $119,724,905,000 after buying an additional 209,879,882 shares during the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of Axon Enterprise by 18,050.2% in the second quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after acquiring an additional 13,127,348 shares in the last quarter. BlackRock Inc. increased its position in shares of Axon Enterprise by 4.3% during the second quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company’s stock valued at $4,672,432,000 after acquiring an additional 345,365 shares during the last quarter. Assenagon Asset Management S.A. increased its position in shares of Axon Enterprise by 5,022.8% during the third quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company’s stock valued at $1,802,719,000 after acquiring an additional 4,183,302 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its holdings in Axon Enterprise by 8,432.6% during the second quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock worth $1,983,414,000 after acquiring an additional 3,496,493 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

About Axon Enterprise

(Get Free Report)

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.